World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0000552755
Reproduction Date:

Title: Steatosis  
Author: World Heritage Encyclopedia
Language: English
Subject: Non-alcoholic fatty liver disease, Pathology, WikiProject Academic Journals/Journals cited by Wikipedia/N25, Steatohepatitis, Alcoholic liver disease
Collection: Histopathology, Pathology
Publisher: World Heritage Encyclopedia


Micrograph demonstrating marked (macrovesicular) steatosis in non-alcoholic fatty liver disease. Masson's trichrome stain.
Histological section of a mouse's liver showing severe steatosis. The clear vacuoles contained lipid in life; however, histological fixation caused it to be dissolved and hence only empty/clear spaces are seen.

In cellular pathology, steatosis (also called fatty change, fatty degeneration or adipose degeneration) is the process describing the abnormal retention of lipids within a cell. It reflects an impairment of the normal processes of synthesis and elimination of triglyceride fat. Excess lipid accumulates in vesicles that displace the cytoplasm. When the vesicles are large enough to distort the nucleus, the condition is known as macrovesicular steatosis; otherwise, the condition is known as microvesicular steatosis. While not particularly detrimental to the cell in mild cases, large accumulations can disrupt cell constituents, and in severe cases the cell may even burst.

The risk factors associated with steatosis are varied, and include

  1. ^ Araya Q AV, et al. (2006). "Glucose tolerance alterations and frequency of metabolic syndrome among patients with non alcoholic fatty liver disease". Rev Med Chil. 134 (9): 1092–1098.  
  2. ^ Conde Martel A, et al. (1993). "Liver changes in protein malnutrition. An experimental study in rats". Nutr Hosp. 8 (6): 358–363.  
  3. ^ MJ Brookes, BT Cooper (2007). "Hypertension and fatty liver: guilty by association?". J Hum Hypertens 21 (4): 264–270.  
  4. ^ S Saadeh (2007). "Nonalcoholic Fatty liver disease and obesity". Nutr Clin Pract. 22 (1): 1–10.  
  5. ^ a b c d Cotran; Kumar, Collins (1998). Robbins Pathologic Basis of Disease. Philadelphia: W.B Saunders Company.  
  6. ^ MH Ahmed, CD Byrne (2010). "Obstructive sleep apnea syndrome and fatty liver: association or causal link?". World J Gastroenterol 16 (34): 4243–52.  
  7. ^ H Singh, R Pollock, J Uhanova, M Kryger, K Hawkins, GY Minuk (2005). "Symptoms of Obstructive Sleep Apnea in Patients with Nonalcoholic Fatty Liver Disease". Digestive Diseases and Sciences 50 (12): 2338–2343.  
  8. ^ F Tanne, F Gagnadoux, O Chazouilleres, B Fleury, D Wendum, E Lasnier, B Labeau, R Poupon, L Serfaty (2005). "Chronic Liver Injury During Obstructive Sleep Apnea". Hepatology 41 (6): 1290–1296.  
  9. ^ Wilson, C.H., Ali, E.S., Scrimgeour, N., Martin, A.M., Hua, J., Tallis, G.A., Rychkov, G.Y., and Barritt, G.J. (2015). Steatosis inhibits liver cell store-operated Ca(2)(+) entry and reduces ER Ca(2)(+) through a protein kinase C-dependent mechanism. Biochem J 466, 379-390.
  10. ^ Bhattacharjee et al, 2010.
  11. ^ Helms, Clyde A.; Brant, William E. (2007). Fundamentals of diagnostic radiology. Phila: Lippincott, Williams & Wilkins.  


See also

(capable of reflecting sound waves). The combination of liver steatosis being dark on CT and bright on ultrasound is sometimes known as the flip flop sign. echogenic On ultrasound, fat is more [11] On

Liver steatosis (fatty liver disease) as seen on CT


Grossly, steatosis causes organ enlargement and lightening in colour.[5] This is due to the high lipid content increasing the organ's volume and becoming visible to the unaided eye. In severe cases, the organ may become vastly enlarged, greasy, and yellow in appearance.

Histologically, steatosis is physically apparent as lipid within membrane bound liposomes of parenchymal cells.[5] When this tissue is fixed and stained to be better viewed under a microscope, the lipid is usually dissolved by the solvents used to prepare the sample. As such, samples prepared this way will appear to have empty holes within the cells where the lipid has been cleared. Special lipid stains, such as Sudan stains and osmium tetroxide are able to retain and show up lipid droplets, hence more conclusively indicating the presence of lipids. Other intracellular accumulations, such as water or glycogen, can also appear as clear vacuoles, therefore it becomes necessary to use stains to better decide what is accumulating.

Micrograph of fatty liver showing lipid steatosis. H&E stain.


Failure of lipid metabolism can also lead to the mechanisms which would normally utilise or remove lipids becoming impaired, resulting in the accumulation of unused lipids in the cell. Certain toxins, such as alcohols, carbon tetrachloride, aspirin, and diphtheria toxin, interfere with cellular machinery involved in lipid metabolism. In those with Gaucher's disease, the lysosomes fail to degrade lipids and steatosis arises from the accumulation of glycolipids. Protein malnutrition, such as that seen in kwashiorkor, results in a lack of precursor apoproteins within the cell, therefore unused lipids which would normally participate in lipoprotein synthesis begin to accumulate.

Microvesicular fatty degeneration is characterized by small intracytoplasmic fat vacuoles (liposomes) which accumulate in the cell. Common causes are tetracyclines, acute fatty liver of pregnancy, Reye's syndrome, and hepatitis C.

Macrovesicular is the more common form of fatty degeneration, and may be caused by oversupply of lipids due to obesity, obstructive sleep apnea (OSA),[10] insulin resistance, or alcoholism. Nutrient malnutrition may also cause the mobilisation of fat from adipocytes and create a local oversupply in the liver where lipid metabolism occurs. Excess alcohol over a long period of time can induce steatosis. The breakdown of large amounts of ethanol in alcoholic drinks produces large amounts of chemical energy, in the form of NADH, signalling to the cell to inhibit the breakdown of fatty acids (which also produces energy) and simultaneously increase the synthesis of fatty acids. This "false sense of energy" results in more lipid being created than is needed.

No single mechanism leading to steatosis exists, rather a varied multitude of pathologies disrupt normal lipid movement through the cell and cause accumulation.[9] These mechanisms can be separated on whether they ultimately cause an oversupply of lipid which can not be removed quickly enough (too much in), or whether they cause a failure in lipid breakdown (not enough used).



  • Pathogenesis 1
  • Histology 2
  • Radiography 3
  • See also 4
  • References 5


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.